Table 1.
Case | Control | p-value | ||
---|---|---|---|---|
Age (year) | 67 ± 10 | 70 ± 8 | 0.34 | |
Sex (male/female) | 11/4 | 10/5 | 0.99 | |
Severity (GOLD criteria) | ||||
I | 0 | 0 | 0.187 | |
II | 0 | 4(27%) | ||
III | 5(33%) | 4(27%) | ||
IV | 10(67%) | 7(47%) | ||
Weight (Kg) | 70±15 | 62±11 | 0.12 | |
Height (cm) | 166±6 | 164±4 | 0.46 | |
Tobacco (pack year) | 23 ± 18 | 22 ± 18 | 0.90 | |
Tobacco>20 pack year | 6(40%) | 7 (47%) | 0.75 | |
History of admission | 9(60%) | 10(67%) | 0.73 | |
Baseline PEFR L/min | 126 ± 76 | 142 ± 62 | 0.64 | |
Baseline FEV1 (% of predicted) | 26 ± 12 | 35 ± 18 | 0.13 | |
Baseline SPO2% | 89 ± 2 | 89 ± 1 | 0.82 | |
Creatinine | 1.17 ± 0.30 | 1.15 ± 0.26 | 0.85 | |
Mg | 2.11 ± 0.28 | 2.05 ± 0.40 | 0.68 |